Clinical Trials
5 trialsNCT03922724 2026-05-22
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT00716066 2026-02-27
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Fred Hutchinson Cancer Center
Phase 2 Active not recruiting
NCT06817889 2026-02-27
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Fred Hutchinson Cancer Center
Phase 2 Recruiting
NCT01545518 2014-09-01
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
Emory University
Phase 2 Terminated
NCT00466843 2009-06-02
Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome
Office of Rare Diseases (ORD)
Phase 2 Unknown